<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Biotechnology News &#187; management-programs</title>
	<atom:link href="http://www.biolexis.com/tag/management-programs/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.biolexis.com</link>
	<description>Biotech news, biotechnology new and biotechnology articles.</description>
	<lastBuildDate>Sat, 31 Jul 2010 12:25:44 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience (News-Medical-Net)</title>
		<link>http://www.biolexis.com/biotechnology-news/3sbio-announces-nephoxil-collaboration-and-license-agreement-with-panacor-bioscience-news-medical-net/</link>
		<comments>http://www.biolexis.com/biotechnology-news/3sbio-announces-nephoxil-collaboration-and-license-agreement-with-panacor-bioscience-news-medical-net/#comments</comments>
		<pubDate>Mon, 08 Feb 2010 11:46:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology News]]></category>
		<category><![CDATA[a-leading-global]]></category>
		<category><![CDATA[and-marketing]]></category>
		<category><![CDATA[and-risk]]></category>
		<category><![CDATA[apcer]]></category>
		<category><![CDATA[china-based]]></category>
		<category><![CDATA[develop-and]]></category>
		<category><![CDATA[leading-global]]></category>
		<category><![CDATA[management-programs]]></category>
		<category><![CDATA[medical-device]]></category>
		<category><![CDATA[panacor]]></category>
		<category><![CDATA[the-treatment]]></category>
		<category><![CDATA[today-announced]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.biolexis.com/biotechnology-news/3sbio-announces-nephoxil-collaboration-and-license-agreement-with-panacor-bioscience-news-medical-net/</guid>
		<description><![CDATA[3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.]]></description>
			<content:encoded><![CDATA[<p>3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.</p>
<p>Read more from the original source: <br />
<a target="_blank" href="http://us.rd.yahoo.com/dailynews/rss/search/biotechnology/SIG=147kt787b/*http://www.news-medical.net/news/20100208/3SBio-announces-Nephoxil-collaboration-and-license-agreement-with-Panacor-Bioscience.aspx" title="3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience (News-Medical-Net)">3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience (News-Medical-Net)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.biolexis.com/biotechnology-news/3sbio-announces-nephoxil-collaboration-and-license-agreement-with-panacor-bioscience-news-medical-net/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Press Release (PharmiWeb)</title>
		<link>http://www.biolexis.com/biotechnology-news/press-release-pharmiweb/</link>
		<comments>http://www.biolexis.com/biotechnology-news/press-release-pharmiweb/#comments</comments>
		<pubDate>Mon, 08 Feb 2010 10:34:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology News]]></category>
		<category><![CDATA[a-leading-global]]></category>
		<category><![CDATA[and-consumer]]></category>
		<category><![CDATA[and-risk]]></category>
		<category><![CDATA[apcer]]></category>
		<category><![CDATA[drug-safety]]></category>
		<category><![CDATA[for-pharmaceutical]]></category>
		<category><![CDATA[leading-global]]></category>
		<category><![CDATA[management-programs]]></category>
		<category><![CDATA[medical-device]]></category>
		<category><![CDATA[products-companies-]]></category>
		<category><![CDATA[regulatory-services]]></category>

		<guid isPermaLink="false">http://www.biolexis.com/biotechnology-news/press-release-pharmiweb/</guid>
		<description><![CDATA[APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.]]></description>
			<content:encoded><![CDATA[<p>APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.</p>
<p>Read more here:<br />
<a target="_blank" href="http://us.rd.yahoo.com/dailynews/rss/search/biotechnology/SIG=124ulr2ro/*http://www.pharmiweb.com/PressReleases/pressrel.asp?ROW_ID=15566" title="Press Release (PharmiWeb)">Press Release (PharmiWeb)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.biolexis.com/biotechnology-news/press-release-pharmiweb/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
